b.adeyemi
TL2 · Odense
Contributes reviews on supplier material. Based in Odense.
Joined 18 March 2025 · last posted 13d · groups: regional-na
79 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #40 · Access › Shortages · 15 Jul 2026 · 13 likes Anyone reporting availability should say the region and the date, because both determine whether the report is usable. I have seen it go both ways, which is why I hedge.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #104 · Evidence › Journal club · 14 Jul 2026 · 18 likes I read post #101 twice before replying, because I had assumed the opposite. Where the group cannot agree, record the disagreement rather than resolving it by seniority.…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #57 · Clinical › Comorbidities · 13 Jul 2026 · 29 likes Worth separating two things that post #55 runs together. The question underneath Osteoarthritis and mechanical versus metabolic is usually "how would I tell?" rather…
-
Seven-day rolling means and why weekly readings mislead Replied, post #9 · Outcomes › Progress reports · 10 Jul 2026 · 0 likes For anyone finding this later: the short answer on seven-day rolling is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #33 · Practice › Side effects · 6 Jul 2026 · 0 likes Adding what did not work for me on Muscle cramps, since the failures never get written up and they are half the useful information.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #58 · Access › International · 5 Jul 2026 · 1 like Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #23 · Compounds › Secretagogues & GH axis · 5 Jul 2026 · 1 like I read post #19 twice before replying, because I had assumed the opposite. A mass result for a short peptide is more discriminating than for a long one, because a…
-
Private prescribing in the UK: what is actually involved Replied, post #51 · Regional › UK & Ireland · 29 Jun 2026 · 30 likes I would rather this thread reach "we do not know" about private prescribing than reach a confident answer that nobody can support when asked.
-
Revisiting: The best-written scientific paper you have read Replied, post #59 · Lounge › Off topic · 29 Jun 2026 · 11 likes Posting my best-written scientific paper numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #13 · Nutrition & Training › Protein & intake · 27 Jun 2026 · 8 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. I would rather say I do not know than round it…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #40 · Start Here › Welcome · 24 Jun 2026 · 3 likes That is a fair summary of where the discussion has got to.
-
Tracking intake honestly when appetite is absent Replied, post #54 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 4 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein. Adding this to the thread rather than to the wiki,…
-
Injecting into an area that has become firm: why not to Replied, post #25 · Practice › Administration · 6 Jun 2026 · 0 likes Thank you — that answers what I came here to find out.
-
Revisiting: Bioimpedance and hydration: why the number moves Replied, post #2 · Outcomes › Body composition · 4 Jun 2026 · 1 like The opening post describes the usual case. This is about the unusual one. Report the method with the number, always. A composition figure without the method is not…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #13 · Sourcing › Red flags · 3 Jun 2026 · 14 likes Post #10 is right about the mechanism and I think understates the practical bit. A certificate that reports a specification in the result column is a documentation…
-
Coming back to: A structured critique template this community uses Replied, post #18 · Evidence › Study critique · 24 May 2026 · 0 likes Where a critique rests on a subgroup, check whether the interaction was tested. A difference between subgroups that is not statistically supported is not a difference.…
-
What a good consultation looks like from the other side Replied, post #40 · Clinical › Prescriber conversations · 13 May 2026 · 8 likes Adding the measurement that post #39 says would settle it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #53 · Compounds › Semaglutide · 10 May 2026 · 0 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #8 · Analytics › Method validation · 28 Apr 2026 · 13 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Bioimpedance and hydration: why the number moves Replied, post #30 · Outcomes › Body composition · 13 Apr 2026 · 7 likes I have three months of notes on bioimpedance and hydration and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Reused chromatograms across lots: how to spot it Replied, post #29 · Analytics › COA interpretation · 25 Mar 2026 · 15 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #70 · Start Here › How to Ask · 5 Mar 2026 · 11 likes Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to understand the chemistry" get very different and equally valid…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #65 · Practice › Dosing & titration · 27 Feb 2026 · 33 likes Where I part company with post #62, and it is a narrow parting. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #117 · Practice › Interactions · 22 Feb 2026 · 5 likes Post #116 answers the question as asked. The question underneath it is different. Reframing Warfarin and altered intake slightly, because I think the disagreement is…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #40 · Start Here › Welcome · 8 Feb 2026 · 18 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What to include when your question involves a chromatogram Replied, post #25 · Start Here › How to Ask · 7 Jan 2026 · 18 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #10 · Practice › Storage & stability · 1 Jan 2026 · 9 likes Offering a way to settle Adsorptive losses rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #122 · Practice › Side effects · 30 Dec 2025 · 0 likes Post #119 is right about the mechanism and I think understates the practical bit. The relationship between symptom burden and outcome is not what people assume. Feeling…
-
DXA precision and the least significant change for lean mass Replied, post #76 · Outcomes › Body composition · 16 Dec 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Personal import allowances, compared Started this topic · Access › International · 16 Dec 2025 · 0 likes On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion. I have spent a fortnight trying to pin personal import…
-
Lurking for two months before posting: was that the right call? Replied, post #43 · Start Here › Welcome · 19 Nov 2025 · 8 likes Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume. Worth saying I…
-
Documentation that materially improves an appeal's chances Replied, post #68 · Access › Insurance & coverage · 18 Nov 2025 · 0 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. Reimbursement changes: a compound covered one year might not be…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #20 · Analytics › Impurities & related substances · 15 Nov 2025 · 0 likes Answering the question post #16 raises rather than the one it answers. Adding a reference point for impurities in solid-phase peptide synthesis. Mine is a single case,…
-
Long-time reader, first-time poster Replied, post #13 · Lounge › Introductions · 12 Nov 2025 · 0 likes I would call the community position on long-time reader likely rather than established, and I would be comfortable defending that hedge.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #79 · Start Here › How to Ask · 10 Nov 2025 · 6 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #29 · Analytics › Method validation · 7 Nov 2025 · 14 likes Understood. Thank you for being specific about the limits of it.
-
Why "add 2 mL" is not an instruction Replied, post #2 · Practice › Reconstitution · 21 Oct 2025 · 15 likes This follows the opening post rather than contradicting it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #26 · Compounds › Tirzepatide · 20 Oct 2025 · 4 likes Where I part company with post #25, and it is a narrow parting. Agreed on SURMOUNT-4, with one qualification that I think matters. The reasoning holds for the case as…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 0 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
-
Sleep quality changes during weight loss — what changed since Replied, post #9 · Wellbeing › Sleep · 26 Sep 2025 · 0 likes What I would want before treating Sleep quality changes during weight as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #70 · Analytics › HPLC & UHPLC · 14 Sep 2025 · 9 likes I keep a log for Resolution and tailing factor specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #12 · Evidence › Study critique · 12 Sep 2025 · 0 likes What I would tell a new member reading about Reverse causation for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #51 · Practice › Storage & stability · 9 Sep 2025 · 7 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
What this community means by "a source", in practical terms Replied, post #101 · Start Here › Welcome · 6 Sep 2025 · 5 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.…
-
Comparing my trajectory with the trial curves, carefully Replied, post #43 · Outcomes › Progress reports · 1 Sep 2025 · 1 like Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #70 · Compounds › Secretagogues & GH axis · 16 Aug 2025 · 24 likes Building on post #67 rather than restating it. Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #7 · Sourcing › Vendor reports · 14 Aug 2025 · 2 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. Photograph the vial and the label before opening. It costs ten seconds and it is what…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #9 · Analytics › HPLC & UHPLC · 15 Jul 2025 · 3 likes Resolution and tailing factor sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side,…
-
Temperature loggers worth the money Replied, post #5 · Devices › Cold chain · 30 Jun 2025 · 22 likes Reframing temperature loggers worth the money slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #10 · Compounds › Secretagogues & GH axis · 25 Jun 2025 · 0 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. IGF-1 as a downstream marker is more informative than a single growth hormone…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #13 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 5 likes What I would check first on Area percent versus weight percent is whether the thing being measured moved or whether the way of measuring it moved. Those look identical…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #18 · Access › Insurance & coverage · 18 Jun 2025 · 3 likes The practical version of Reading a denial letter is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #106 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 0 likes Coming back to post #102, because the follow-up matters more than the original answer. Micronutrient adequacy becomes a real question at very low total intake and is…
-
Half-life, steady state, and accumulation worked through Replied, post #100 · Pharmacology › Pharmacokinetics · 11 Jun 2025 · 16 likes Where I part company with post #96, and it is a narrow parting. Before the thread moves on from half-life — what is the sample size behind the claim? I am not being…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #123 · Practice › Reconstitution · 2 Jun 2025 · 2 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
A page that has drifted out of date and needs a maintainer Replied, post #95 · Documentation › Wiki requests · 27 Apr 2025 · 21 likes Answering the question post #91 raises rather than the one it answers. A page that would need to be rewritten every quarter is usually better as a topic with a good…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #35 · Compounds › Repair & healing peptides · 17 Apr 2025 · 20 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #6 · Data & Tools › Calculators · 6 Apr 2025 · 1 like Worth separating two things that post #2 runs together. Before the thread moves on from Validating a calculator against hand — what is the sample size behind the claim?…
-
Consistent declarations and why they matter more than clever ones Replied, post #153 · Sourcing › Logistics · 9 Mar 2025 · 16 likes Post #152 describes the usual case. This is about the unusual one. What I would tell a new member reading about consistent declarations for the first time: the…
-
Charge states for a 4 kDa peptide, worked through Replied, post #45 · Analytics › Mass spectrometry · 7 Mar 2025 · 5 likes This follows post #42 rather than contradicting it. Reading this charge states thread as someone who came in with a fixed view: the third and seventh replies moved me…
-
Canadian access and provincial variation Replied, post #73 · Regional › North America · 9 Feb 2025 · 8 likes Post #71 put the caveat in the right place and I want to underline it. The question underneath canadian access and provincial variation is usually "how would I tell?"…
-
What changed in 2026, by region Replied, post #86 · Access › International · 19 Jan 2025 · 4 likes Everything in post #82 holds. The case it does not cover is the one I have. The most useful thing anyone can add to a thin regional thread is what the official source…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #10 · Data & Tools › Calculators · 8 Jan 2025 · 1 like Adding a null result on feature request. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Hello from a laboratory that does not do peptides — does this still hold? Replied, post #6 · Lounge › Introductions · 7 Jan 2025 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people. I…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #136 · Practice › Dosing & titration · 28 Dec 2024 · 19 likes Taking post #135 at face value and following it one step further. I would keep four-week escalation interval and the decision it usually gets used for separate in this…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #56 · Compounds › Oral incretins · 26 Dec 2024 · 30 likes Post #54 describes the usual case. This is about the unusual one. Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #23 · Analytics › Mass spectrometry · 21 Dec 2024 · 6 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. I would be glad to be…
-
Converting between mg/mL and units per dose, both directions Replied, post #134 · Practice › Reconstitution · 17 Dec 2024 · 11 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Coming back to: When to suspect the method rather than the sample Replied, post #65 · Analytics › Method validation · 13 Dec 2024 · 0 likes Worth separating two things that post #61 runs together. Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH,…
-
Why "any advice?" is the least effective ending for a post Replied, post #100 · Start Here › How to Ask · 3 Dec 2024 · 14 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #75 · Analytics › Method validation · 18 Nov 2024 · 6 likes Stability-indicating method is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #2 · Devices › Cold chain · 20 Oct 2024 · 1 like Domestic fridge temperature mapping is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #25 · Practice › Administration · 13 Sep 2024 · 22 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #19 · Sourcing › Independent verification · 27 Aug 2024 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
-
Correlation in a self-tracked dataset: what it can support Replied, post #152 · Research Methods › Statistics · 26 Aug 2024 · 4 likes Post #151 answers the question as asked. The question underneath it is different. A definition problem is doing most of the work in this correlation discussion. Once…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #10 · Practice › Interactions · 13 Aug 2024 · 2 likes Agreed on all of that, and I have nothing to add to it.
-
Chronic kidney disease and the FLOW result Replied, post #8 · Clinical › Comorbidities · 11 Aug 2024 · 0 likes Taking chronic kidney disease seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
How this community labels and discusses unrefereed work Replied, post #61 · Evidence › Preprints · 5 Jul 2024 · 4 likes Community labels sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
What happens when a maintainer goes quiet Replied, post #3 · Documentation › Doc review · 18 Jun 2024 · 22 likes The opening post put the caveat in the right place and I want to underline it. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it…